Nosocomial Infection Clinical Trial
Official title:
Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients
Hospital acquired chest Infections are common complications in hospitalized cirrhotic patients. Infectious complications are the most common cause of mortality in cirrhotic patients with bronchopneumonia early antibiotic treatment at the base of culture and sensitivity is an optimal therapeutic approach in cirrhotics with nosocomial pneumonia Intensive care unit acquired pneumonia is the leading infection in critically ill patients and a major cause of morbidity and mortality despite recent major advances in antimicrobial therapy, supportive care, and the use of a broad range of preventive measures
Aim of the work
1. To estimate the frequency and risk factors of nosocomial chest infections in cirrhotic
patients .
2. To determine the causative pathogens of nosocomial chest infections in patients with
cirrhosis including fungal infections in order to establish our local empirical
antimicrobial protocol.
3. To define the impact of nosocomial chest infections on survival of our patients.
4. To develop an effective and continuous surveillance program and infection control
measures to reduce the burden of these infections as well as morbidity , mortality ,
hospital stay ,hospital cost and to achieve quality of care .
5. To motivate pharmaceutical companies to create a new umbrella coverage of antimicrobials
through the ongoing knowledge of the changes in microbial resistance pattern inside
hospitals
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
| Recruiting |
NCT05904535 -
Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections
|
||
| Completed |
NCT01704430 -
Glutamine to Improve Outcomes in Cardiac Surgery
|
N/A | |
| Terminated |
NCT01225159 -
Tight Glycaemic Control During Cardiac Surgery
|
N/A | |
| Recruiting |
NCT04659356 -
NOSOcomial COVID-19 in ICU (NOSOCOVID)
|
||
| Terminated |
NCT03423147 -
Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor
|
Phase 2 | |
| Completed |
NCT03429283 -
Achromobacter Xylosoxidans (ACHX) Infections
|
||
| Recruiting |
NCT04252651 -
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
|
||
| Completed |
NCT04405934 -
COG-UK Project Hospital-Onset COVID-19 Infections Study
|
N/A | |
| Active, not recruiting |
NCT03865706 -
Inulin for Infections in the Intensive Care Unit
|
Phase 2 | |
| Recruiting |
NCT05411562 -
COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations
|
||
| Completed |
NCT03250104 -
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
|
||
| Completed |
NCT01763008 -
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
|
Phase 4 | |
| Completed |
NCT00864929 -
An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice
|
N/A | |
| Terminated |
NCT01515020 -
Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
|
Phase 3 | |
| Active, not recruiting |
NCT05511129 -
Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU
|
||
| Completed |
NCT04212130 -
Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method
|
N/A | |
| Active, not recruiting |
NCT05988853 -
Biosafety of Musical Instruments in the ICU
|
||
| Recruiting |
NCT01943331 -
Epidemiological Investigation of CRBSI, VAP, CAUTI in Chinese ICU
|
N/A | |
| Completed |
NCT00105625 -
VA Nutrition Study on Immune Function
|
N/A |